These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2487 related articles for article (PubMed ID: 8093465)

  • 61. Ocular penetration, toxicity, and radiosensitization effects of two hypoxic cell radiosensitizers on retinoblastoma.
    Rootman J; Gallie B; Kumi C; Bussanich N; Rogers B; Palcic B
    Arch Ophthalmol; 1986 Nov; 104(11):1693-7. PubMed ID: 2946282
    [TBL] [Abstract][Full Text] [Related]  

  • 62. A multiple dose study of the combined radiosensitizers Ro 03-8799 (pimonidazole) and SR 2508 (etanidazole).
    Bleehen NM; Newman HF; Maughan TS; Workman P
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1093-6. PubMed ID: 2539346
    [TBL] [Abstract][Full Text] [Related]  

  • 63. A phase I study of the combined hypoxic cell radiosensitizers, Ro 03-8799 and SR 2508: a preliminary report of single-dose toxicity, pharmacokinetics and tumour concentrations.
    Newman HF; Bleehen NM; Workman P
    Br J Radiol; 1986 Apr; 59(700):423-5. PubMed ID: 2938660
    [No Abstract]   [Full Text] [Related]  

  • 64. Autoradiographic distribution of [14C]-labelled pimonidazole in rhabdomyosarcoma-bearing rats and pigmented mice.
    Laurent F; Benard P; Canal P; Soula G
    Cancer Chemother Pharmacol; 1988; 22(4):308-15. PubMed ID: 3168144
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of fabrication conditions on the characteristics of etanidazole spray-dried microspheres.
    Wang FJ; Wang CH
    J Microencapsul; 2002; 19(4):495-510. PubMed ID: 12396386
    [TBL] [Abstract][Full Text] [Related]  

  • 66. DNA topoisomerase I content of a pair of human melanoma cell lines with very different radiosensitivities correlates with their in vitro sensitivities to camptothecin.
    Ng CE; Cybulski SE; Bussey AM; Aubin RA; Raaphorst GP
    Anticancer Res; 1998; 18(4C):3119-26. PubMed ID: 9713520
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Radiosensitization of paclitaxel, etanidazole and paclitaxel+etanidazole nanoparticles on hypoxic human tumor cells in vitro.
    Jin C; Bai L; Wu H; Tian F; Guo G
    Biomaterials; 2007 Sep; 28(25):3724-30. PubMed ID: 17509678
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The efficacy of pharmacokinetic monitoring and dose modification of etanidazole on the incidence of neurotoxicity: results from a phase II trial of etanidazole and radiation therapy in locally advanced prostate cancer.
    Coleman CN; Buswell L; Noll L; Riese N; Rose MA
    Int J Radiat Oncol Biol Phys; 1992; 22(3):565-8. PubMed ID: 1310497
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Initial results of a phase I trial of continuous infusion SR 2508 (etanidazole): a radiation therapy oncology group study.
    Coleman CN; Noll L; Howes AE; Harris JR; Zakar J; Kramer RA
    Int J Radiat Oncol Biol Phys; 1989 Apr; 16(4):1085-7. PubMed ID: 2522919
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Inhibition of constitutively activated nuclear factor-kappaB radiosensitizes human melanoma cells.
    Munshi A; Kurland JF; Nishikawa T; Chiao PJ; Andreeff M; Meyn RE
    Mol Cancer Ther; 2004 Aug; 3(8):985-92. PubMed ID: 15299081
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The prognostic value of pimonidazole and tumour pO2 in human cervix carcinomas after radiation therapy: a prospective international multi-center study.
    Nordsmark M; Loncaster J; Aquino-Parsons C; Chou SC; Gebski V; West C; Lindegaard JC; Havsteen H; Davidson SE; Hunter R; Raleigh JA; Overgaard J
    Radiother Oncol; 2006 Aug; 80(2):123-31. PubMed ID: 16890316
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In vivo drug screening method of radiosensitizers using tumor-bearing chick embryo.
    Uto Y; Abe C; Futawaka M; Yamada H; Tominaga M; Endo Y
    Enzymes; 2019; 46():113-127. PubMed ID: 31727273
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Depigmentation in melanomas increases the efficacy of hypericin-mediated photodynamic-induced cell death.
    Sharma KV; Davids LM
    Photodiagnosis Photodyn Ther; 2012 Jun; 9(2):156-63. PubMed ID: 22594986
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oncogenic transforming potential of etanidazole.
    Hall EJ; Hei TK
    Int J Radiat Oncol Biol Phys; 1992; 22(4):743-5. PubMed ID: 1531978
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Experimental boron neutron capture therapy for melanoma: systemic delivery of boron to melanotic and amelanotic melanoma.
    Coderre JA; Glass JD; Packer S; Micca P; Greenberg D
    Pigment Cell Res; 1990 Dec; 3(6):310-8. PubMed ID: 2101931
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The relationship of SR-2508 sensitizer enhancement ratio to cellular glutathione levels in human tumor cell lines.
    Mitchell JB; Phillips TL; DeGraff W; Carmichael J; Rajpal RK; Russo A
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1143-6. PubMed ID: 2943712
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Schedule dependent tumour growth delay, DNA cross-linking and pharmacokinetic parameters in target tissues with cis-diamminedichloroplatinum(II) and etanidazole with or without hyperthermia or radiation.
    Teicher BA; Pfeffer MR; Alvarez Sotomayor E; Herman TS
    Int J Hyperthermia; 1991; 7(5):773-84. PubMed ID: 1834752
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Simulation of intratumoral release of Etanidazole: effects of the size of surgical opening.
    Tan WH; Lee T; Wang CH
    J Pharm Sci; 2003 Apr; 92(4):773-89. PubMed ID: 12661063
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Modulation of alkylating agents by etanidazole and Fluosol-DA/carbogen in the FSaIIC fibrosarcoma and EMT6 mammary carcinoma.
    Teicher BA; Herman TS; Tanaka J; Eder JP; Holden SA; Bubley G; Coleman CN; Frei E
    Cancer Res; 1991 Feb; 51(4):1086-91. PubMed ID: 1825474
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Radiosensitizing, toxicological, and pharmacokinetic properties of hydroxamate analogues of nitroimidazoles as bifunctional radiosensitizers/chemical modifiers.
    Nagasawa H; Bando M; Hori H; Satoh T; Tada T; Onoyama Y; Inayama S
    Int J Radiat Oncol Biol Phys; 1992; 22(3):561-4. PubMed ID: 1735696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 125.